Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Zoster Vaccine in People Living With HIV
NCT05898464Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2023
- Primary completion
- Feb 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by Seoul National University Hospital. Started Jun 2023; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT05898464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05898464.